E. Too far off per trial protocol post hoc work to fit the results to a subgroup win supported by OLE data. All great stuff for designing the confirmatory P3 trial Anavex should have initiated when they said that was the plan more than 2 years ago.
Congratulations 12x! You win the FUD award of the year!🏆 That took a lot of work and VERY convincing, There is no way this will ever get approved causing harm to patients!